Professor
University of British Columbia
University of British Columbia
Vancouver, British Columbia, Canada
Current Positions:
Professor, Department of Cellular & Physiological Sciences
Department of Surgery
School of Biomedical Engineering
University of British Columbia
Chief Scientific Officer, Fractyl Health
Dr. Kieffer’s laboratory is focused on the development of novel gene and cell therapy approaches to treat diabetes. He has co-authored >200 peer reviewed publications on these topics that have been cited >20,000 times. He has mentored >40 graduate students and postdoctoral fellows in addition to numerous undergraduates and is an active teacher. He has received scholarships from the Canadian Diabetes Association (CDA), the Alberta Heritage Foundation for Medical Research, the Michael Smith Foundation for Health Research, and JDRF and his research has been supported by these agencies, in addition to the Canadian Institutes of Health Research (CIHR), Canadian Foundation for Innovation and the Stem Cell Network. Dr. Kieffer has also been a reviewer and member of grants review committees for these agencies, including serving as Scientific Officer and Chair on CIHR and CDA committees. In 2010 he received the CDA Young Scientist Award and in 2018 was elected as a Fellow of the Canadian Academy of Health Sciences. In 2016/17 he spent 1 year on sabbatical at The Center for iPS Cell Research and Application (CiRA), Kyoto University. In 2021/22 he took a 1 year leave-of-absence from UBC to serve as Chief Scientific Officer at ViaCyte, and in 2023 he joined Fractyl Health as Chief Scientific Officer.
Thursday, November 21, 2024
09:00 - 10:00 AT Time
Disclosure(s): Aspect Biosystems: Grant/Research Support (Terminated); Fractyl Health: Employment (Ongoing); Sigilon: Consultant (Terminated); ViaCyte: Employment (Terminated), Other Research Support (includes receipt of drugs, supplies, equipment or other in-kind support) (Terminated)